European Drugs and Addiction library

Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age


Some new drugs appear to have a limited potential for diffusion, but they may still cause serious harm. Stakeholders, including policy makers, practitioners and researchers, will increasingly need access to timely evidence-based information on new drugs


This abstract is provided here as a convenience only. Check the publisher's website (if available) for the definitive version.

There is a need to review the various regulatory options that are available in order to address the challenge presented by a plethora of new psychoactive substances appearing on the market as well as to address the technology for rapid development and marketing of new ones.